Susquehanna International Group, LLP Ventyx Biosciences, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.85 - $3.2 $291,190 - $503,680	-157,400 Reduced 77.73%	45,100 $98,000
Q2 2024 Aug 15, 2024	BUY	$2.31 - $5.59 $161,469 - $390,741	69,900 Added 52.71%	202,500 $467,000
Q1 2024 May 07, 2024	BUY	$1.9 - $10.13 $191,900 - $1.02 Million	101,000 Added 319.62%	132,600 $729,000
Q4 2023 Feb 14, 2024	SELL	$2.08 - $31.18 $124,592 - $1.87 Million	-59,900 Reduced 65.46%	31,600 $78,000
Q3 2023 Nov 14, 2023	SELL	$29.8 - $40.3 $2.1 Million - $2.84 Million	-70,500 Reduced 43.52%	91,500 $3.18 Million
Q2 2023 Aug 11, 2023	BUY	$28.53 - $39.55 $3.62 Million - $5.02 Million	127,000 Added 362.86%	162,000 $5.31 Million
Q1 2023 May 16, 2023	BUY	$29.51 - $46.65 $1.03 Million - $1.63 Million	35,000 New	35,000 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $452,512 - $1.39 Million	35,800 New	35,800 $1.25 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $128M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.